Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

OxiSelect™ Total Antioxidant Capacity (TAC) Assay Kit

BCA Reactivité: Others Cell Lysate, Plasma, Serum, Urine
N° du produit ABIN2345024
  • Reactivité
    Others
    Application
    Biochemical Assay (BCA)
    Fonction
    OxiSelect™ TAC Assay Kit measures the total antioxidant capacity within a sample.
    Marque
    OxiSelect™
    Type d'échantillon
    Cell Lysate, Serum, Plasma, Urine
    Attributs du produit
    OxiSelect™ Total Antioxidant Capacity (TAC) Assay Kit measures the total antioxidant capacity of biomolecules from a variety of samples via a SET mechanism. The TAC Assay is based on the reduction of copper (II) to copper (I) by antioxidants such as uric acid. Upon reduction, the copper (I) ion further reacts with a coupling chromogenic reagent that produces a color with a maximum absorbance at 490 nm. The net absorbance values of antioxidants are compared with a known uric acid standard curve. Absorbance values are proportional to the sample's total reductive capacity. Results are expressed as ""μM Copper Reducing Equivalents"" or "" mM Uric Acid Equivalents"". Copper is advantageous over iron-based antioxidant assays because all classes of antioxidants, including thiols, are detected with marginal radical interference. In addition, the kinetics of the copper-based reaction is also faster than the iron-based reaction, which makes the TAC Assay an ideal tool for estimating reductive or antioxidant capacity efficiently and accurately. OxiSelect™ TAC Assay Kit is a fast and reliable kit for the direct measurement of total antioxidant capacity from cell lysate, plasma, serum, urine, tissue homogenates, and food extracts. Each kit provides sufficient reagents to perform up to 200 assays, including blanks, antioxidant standards and unknown samples. Hydrophilic and lipophilic samples are compatible with the assay.
    Ingrédients
    1. Uric Acid Standard : One 100 mg tube of powder.
    2. Reaction Buffer (100X) : One 400 μL amber vial.
    3. Copper Ion Reagent (100X) : One 1.0 mL vial.
    4. Stop Solution (10X) : One 1.5 mL vial. 3
    Matériel non inclus
    1. Standard 96-well microtiter plates for use in microplate reader
    2. 1N NaOH, 1X PBS and deionized water
    3. Methanol or other organic solvent for lipid-based samples
    4. Sonicator or homogenizer for sample preparations
    5. 10 μL to 1000 μL adjustable single channel micropipettes with disposable tips
    6. 50 μL to 300 μL adjustable multichannel micropipette with disposable tips
    7. Spectrophotometric microplate reader capable of reading 490 nm
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Commentaires

    • Measures total antioxidant capacity based on reduction of copper(II) to copper(I)
    • Suitable for use with plasma, serum, urine, cell lysates, tissue homogenates and food extracts
    • Works with a wide variety of antioxidants

    Protocole
    Samples are compared to a known concentration of uric acid standard within a 96-well microtiter plate format. Samples and standards are diluted with a reaction reagent and, upon the addition of copper, the reaction proceeds for a few minutes. The reaction is stopped and read with a standard 96-well spectrophotometric microplate reader at 490 nm . Antioxidant capacity is determined by comparison with the uric acid standards.
    Préparation des réactifs

    Reagents may be prepared for either hydrophilic or lipophilic samples. Although many lipophilic samples are soluble upon dilution with 1X PBS, the kit reagents may be prepared in methanol to ensure complete solubility.

    • 1X Reaction Buffer: Dilute the Reaction Buffer 1:100 with 1X PBS (hydrophilic) or with methanol (lipophilic). Mix to homogeneity. Store the 1X Reaction Buffer at 4 °C up to three months.
    • 1X Copper Ion Reagent: Dilute the Copper Ion Reagent 1:100 with deionized water (hydrophilic) or with methanol (lipophilic). Mix to homogeneity. Store the 1X Copper Ion Reagent at 4 °C up to three months.
    • 1X Stop Solution: Dilute the Stop Solution 1:10 with deionized water (hydrophilic) or with methanol (lipophilic). Mix to homogeneity. Store the 1X Stop Solution at 4 °C up to three months.

    Préparation de l'échantillon

    Samples should be stored at -80 °C prior to performing the assay. Samples should be prepared at the discretion of the user. The following recommendations are only guidelines and may be altered to optimize or complement the user's experimental design. Note: EDTA can interfere with the TAC assay and should not be present in any sample.

    • Tissue Lysate: Sonicate or homogenize tissue sample on cold PBS and centrifuge at 10,000 x g for 10 minutes at 4 °C. Aliquot the supernatant for storage at -80 °C, protein determination and subsequent TAC assay.
    • Cell Culture: Wash cells 3 times with cold PBS prior to lysis. Lyse cells with sonication or homogenation in cold PBS and centrifuge at 10,000 x g for 10 minutes at 4 °C. Aliquot the supernatant for storage at -80 °C, protein determination and subsequent TAC assay.
    • Plasma: Collect blood with heparin and centrifuge at 4 °C for 10 minutes. Remove the plasma and aliquot samples for testing.
    • Urine: Test neat or diluted with PBS if appropriate. 4
    • Lipophilic Fractions: Dissolve lipophilic samples in 100 % methanol or acetone and then dilute in 50 % methanol or acetone. Incubate the mixture for 1 hour at room temperature with mixing. Further dilute samples as necessary prior to testing.
    • Food Samples: Results may vary depending on sample source and purification. Dilution and preparation of these samples is at the discretion of the user, but use the following guidelines: o Solid or High Protein Samples: Weigh solid sample and then homogenize after adding deionized water (1:2, w/v). Centrifuge the homogenate at 10,000 x g for 10 minutes at 4 °C. Recover the supernatant which is the water-soluble fraction. The insoluble fraction (pulp) is further extracted by adding pure acetone (1:4, w(solid pulp)/v) and mixing at room temperature for 30-60 minutes. Centrifuge the extract/solid at 10,000 x g for 10 minutes at 4 °C. Recover the acetone extract and dilute with PBS or water as necessary prior to running the assay. The TAC value is calculated by combining the results from the water-soluble fraction and the acetone extract from the pulp fraction. o Aqueous Samples: Centrifuge the sample at 10,000 x g for 10 minutes at 4 °C to remove any particulates. Dilute the supernatant in PBS as necessary prior to running the assay. Certain liquids such as juice extracts may be tested without dilution.

    Procédure de l'essai

    Each Uric Acid Standard and sample should be assayed in duplicate or triplicate. A freshly prepared standard curve should be used each time the assay is performed.

    1. Add 20 μL of the diluted Uric Acid Standards or samples to the 96-well microtiter plate.
    2. Add 180 μL of the 1X Reaction Buffer to each well using either a multichannel pipette or a plate reader liquid handling system. Mix thoroughly.
    3. Obtain an initial absorbance by reading the plate at 490 nm.
    4. To initiate the reaction, add 50 μL of the 1X Copper Ion Reagent into each well. Incubate 5 minutes on an orbital shaker.
    5. Add 50 μL of 1X Stop Solution to each well to terminate the reaction.
    6. Read the plate again at 490 nm.

    Calcul des résultats
    1. Calculate the net absorbance by subtracting the initial absorbance readings for samples and standards (Step 3) from the final readings taken for each (Step 6).
    2. Plot the net absorbance against the uric acid concentration for the uric acid standard curve.
    3. Calculate the antioxidant capacity of unknown samples by comparing the net OD 490 nm values of samples to the uric acid standard curve. To determine the " mM uric acid equivalents" (UAE) for samples, extrapolate the uric acid concentration from the sample's analogous uric acid OD 490 nm value (For example, based on the sample standard curve above, an OD 490 nm value of 1.0 corresponds to 0.75 mM uric acid equivalents (UAE)). To determine "μM Copper Reducing Equivalents" (CRE) for samples, multiply the uric acid equivalence (UAE) concentration by 2189 μM Cu++/ mM uric acid. 1 mM of uric acid = 2189 μM Copper Reducing Equivalents. (For example, 0.75 mM UAE x 2189 = 1642 Copper Reducing Equivalents (CRE)). CRE sample values are proportional to the sample's Total Antioxidant Capacity or Total Antioxidant Power.
    Restrictions
    For Research Use only
  • Stock
    RT/4 °C
    Stockage commentaire
    Upon receipt store the Reaction Buffer (100X) at 4°C. Store all remaining kit components at room temperature until their expiration dates.
  • Kim, Kim, Lee, Kuk, Kim, Kim, Kweon: "Comparison of viability and antioxidant capacity between canine adipose-derived mesenchymal stem cells and heme oxygenase-1-overexpressed cells after freeze-thawing." dans: The Journal of veterinary medical science / the Japanese Society of Veterinary Science, (2016) (PubMed).

    Milewski, Hilgier, Fr??ko, Polowy, Podsiad?owska, Zo?oci?ska, Grymanowska, Filipkowski, Albrecht, Zieli?ska: "Carnosine Reduces Oxidative Stress and Reverses Attenuation of Righting and Postural Reflexes in Rats with Thioacetamide-Induced Liver Failure." dans: Neurochemical research, Vol. 41, Issue 1-2, pp. 376-84, (2016) (PubMed).

    Wang, Utell, Schneider, Zareba, Frampton, Oakes, Hopke, Wiltshire, Kane, Peters, Breitner, Chalupa, Rich: "Does total antioxidant capacity modify adverse cardiac responses associated with ambient ultrafine, accumulation mode, and fine particles in patients undergoing cardiac rehabilitation?" dans: Environmental research, Vol. 149, pp. 15-22, (2016) (PubMed).

    Patel, Akalkotkar, Bivona, Lee, Park, Yu, Colpitts, Vajdy: "Vitamin A or E and a catechin synergize as vaccine adjuvant to enhance immune responses in mice by induction of early interleukin-15 but not interleukin-1β responses." dans: Immunology, Vol. 148, Issue 4, pp. 352-62, (2016) (PubMed).

    Ciesla, Marona, Kozakowska, Jez, Seczynska, Loboda, Bukowska-Strakova, Szade, Walawender, Kusior, Stepniewski, Szade, Krist, Yagensky, Urbanik, Kazanowska, Dulak, Jozkowicz: "Heme Oxygenase-1 Controls an HDAC4-miR-206 Pathway of Oxidative Stress in Rhabdomyosarcoma." dans: Cancer research, Vol. 76, Issue 19, pp. 5707-5718, (2016) (PubMed).

    Harisa, Alomrani, Badran: "Simvastatin-loaded nanostructured lipid carriers attenuate the atherogenic risk of erythrocytes in hyperlipidemic rats." dans: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Vol. 96, pp. 62-71, (2016) (PubMed).

    Braud, Battault, Meyer, Nascimento, Gaillard, de Sousa, Rahmani, Riva, Armand, Maixent, Reboul: "Antioxidant properties of tea blunt ROS-dependent lipogenesis: beneficial effect on hepatic steatosis in a high fat-high sucrose diet NAFLD obese rat model." dans: The Journal of nutritional biochemistry, Vol. 40, pp. 95-104, (2016) (PubMed).

    Lao, Jiang, Yun, Qiu, Guo, Huang, Mancini, Gupta, Laucho-Contreras, Naing, Zhang, Perrella, Owen, Silverman, Zhou: "Hhip haploinsufficiency sensitizes mice to age-related emphysema." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Issue 32, pp. E4681-7, (2016) (PubMed).

    Kawano, Murata, Hyodo, Eto, Kosem, Nakata, Hamano, Piao, Narahara, Akahoshi, Hashizume: "Noninvasive mapping of the redox status of dimethylnitrosamine-induced hepatic fibrosis using in vivo dynamic nuclear polarization-magnetic resonance imaging." dans: Scientific reports, Vol. 6, pp. 32604, (2016) (PubMed).

    Javanbakht, Djalali, Daneshpazhooh, Zarei, Eshraghian, Derakhshanian, Chams-Davatchi: "Evaluation of antioxidant enzyme activity and antioxidant capacity in patients with newly diagnosed pemphigus vulgaris." dans: Clinical and experimental dermatology, Vol. 40, Issue 3, pp. 313-7, (2015) (PubMed).

    Antonopoulos, Margaritis, Coutinho, Shirodaria, Psarros, Herdman, Sanna, De Silva, Petrou, Sayeed, Krasopoulos, Lee, Digby, Reilly, Bakogiannis, Tousoulis, Kessler, Casadei, Channon, Antoniades: "Adiponectin as a link between type 2 diabetes and vascular NADPH oxidase activity in the human arterial wall: the regulatory role of perivascular adipose tissue." dans: Diabetes, Vol. 64, Issue 6, pp. 2207-19, (2015) (PubMed).

    Youn, Chen, Furgeson: "Cytoprotection against beta-amyloid (A?) peptide-mediated oxidative damage and autophagy by Keap1 RNAi in human glioma U87mg cells." dans: Neuroscience research, Vol. 94, pp. 70-8, (2015) (PubMed).

    Beretta, Folini, Cavalieri, Yan, Fresch, Kaliappan, Hasenöhrl, Richardson, Tinelli, Fery, Caruso, Zaffaroni: "Unravelling "off-target" effects of redox-active polymers and polymer multilayered capsules in prostate cancer cells." dans: Nanoscale, Vol. 7, Issue 14, pp. 6261-70, (2015) (PubMed).

    Liu, Park, Wu, Li, Tran, Mun, Lee, Hur, Wen, Park: "Shen-Kang protects 5/6 nephrectomized rats against renal injury by reducing oxidative stress through the MAPK signaling pathways." dans: International journal of molecular medicine, Vol. 36, Issue 4, pp. 975-84, (2015) (PubMed).

    Agar, Dikmen, Ozturk, Yilmaz, Temel, Turkmenoglu: "Comparative Studies on Phenolic Composition, Antioxidant, Wound Healing and Cytotoxic Activities of Selected Achillea L. Species Growing in Turkey." dans: Molecules (Basel, Switzerland), Vol. 20, Issue 10, pp. 17976-8000, (2015) (PubMed).

    Ni, Zheng, Xiong, Hill, Sun, Gardiner, Fan, Lu, Abel, Greer, Peng: "Mitochondrial Calpain-1 Disrupts ATP Synthase and Induces Superoxide Generation in Type 1 Diabetic Hearts: A Novel Mechanism Contributing to Diabetic Cardiomyopathy." dans: Diabetes, Vol. 65, Issue 1, pp. 255-68, (2015) (PubMed).

    Alagbonsi, Olayaki, Salman: "Melatonin and vitamin C exacerbate Cannabis sativa-induced testicular damage when administered separately but ameliorate it when combined in rats." dans: Journal of basic and clinical physiology and pharmacology, (2015) (PubMed).

    Wu, Hafner, Schramel, Kaun, Krychtiuk, Wojta, Boehme, Ullrich, Tretter, Markstaller, Klein: "Cyclic and constant hyperoxia cause inflammation, apoptosis and cell death in human umbilical vein endothelial cells." dans: Acta anaesthesiologica Scandinavica, (2015) (PubMed).

    Stensland, Kim, Bowring, Collins, Mansfield, Pluske et al.: "A Comparison of Diets Supplemented with a Feed Additive Containing Organic Acids, Cinnamaldehyde and a Permeabilizing Complex, or Zinc Oxide, on Post-Weaning Diarrhoea, Selected Bacterial ..." dans: Animals : an open access journal from MDPI, Vol. 5, Issue 4, pp. 1147-68, (2015) (PubMed).

    Girgih, Alashi, He, Malomo, Raj, Netticadan, Aluko: "A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats." dans: Nutrients, Vol. 6, Issue 12, pp. 5652-66, (2015) (PubMed).

  • Sujet
    Oxidative stress is a physiological condition where there is an imbalance between concentrations of reactive oxygen species (ROS) and antioxidants. However, excessive ROS accumulation will lead to cellular injury, such as damage to DNA, proteins, and lipid membranes. The cellular damage caused by ROS has been implicated in the development of many disease states, such as cancer, diabetes, cardiovascular disease, atherosclerosis, and neurodegenerative diseases. Under normal physiological conditions, cellular ROS generation is counterbalanced by the action of cellular antioxidant enzymes, macro or micro molecules, as well as other redox molecules. Antioxidants also include both hydrophilic and lipophilic molecules for metabolizing ROS. These may be localized transiently within different tissues or cells. Because of their potential harmful effects, excessive ROS must be promptly eliminated from the cells by this variety of antioxidant defense mechanisms. Although the products of ROS-induced oxidative stress are extensively used to monitor their biological effects, it is also important to evaluate the antioxidant capacity of biological fluids, cells, and extracts. Antioxidants commonly neutralize radicals via a hydrogen atom transfer (HAT) or single electron transfer (SET) mechanism. SET assays quantify the capability of an antioxidant to transfer one electron to reduce any compound, such as free radicals, carbonyls, and metals.
Vous êtes ici:
Support technique